Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1096 of 6351
-
High-Dose cocktail shows promise against new myeloma
Disease control CompletedThe purpose of this study is to test whether giving high doses of carfilzomib along with the other drugs (lenalidomide and dexamethasone) is safe and which dose is best tolerated by patients. In addition, the study is designed to test the amount of remaining myeloma cells in the …
Phase 1/2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can Ice-Cold saline save trauma victims in cardiac arrest?
Disease control Stopped earlyThe goal of this study is to rapidly cool trauma victims who have suffered cardiac arrest from bleeding with a flush of ice-cold sodium chloride to preserve the patient to enable surgical control of bleeding, followed by delayed resuscitation with cardiopulmonary bypass.
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Elderly cancer patients may benefit from geriatric support
Disease control CompletedRandomized trials have already demonstrated that geriatric intervention was able to improve survival in the general elderly population but only a few have been performed in cancer patients. At the end, these data are not sufficient to consider geriatric intervention as validated …
Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo shows promise for aggressive breast cancer
Disease control CompletedThis phase IIB trial studies how well enzalutamide and paclitaxel before surgery works in treating patients with stage I-III androgen receptor-positive triple-negative breast cancer. Androgens can cause the growth of triple-negative breast cancer. Anti-hormone therapy, such as en…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could rerouting the gut and cutting nerves free people from diabetes drugs?
Disease control CompletedSurgical Treatment in Diabetic Patients With Grade 1 Obesity
Sponsor: Universidade Positivo • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for tough breast cancers: drug combo targets tumors in body and brain
Disease control CompletedThis randomized phase II trial studies how well cisplatin works with or without veliparib in treating patients with triple-negative breast cancer and/or BRCA mutation-associated breast cancer that has come back (recurrent) or has or has not spread to the brain (brain metastases).…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Promising hybrid procedure aims to tame stubborn AFib
Disease control By invitation onlyMinimally invasive surgical procedures have been advocated as an alternative to catheter ablation for the treatment of persistent atrial fibrillation. Initial results have been promising in maintaining sinus rhythm compared to catheter ablation, but are associated with a consider…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Promising new combo for Hard-to-Treat breast cancer
Disease control OngoingThe main purpose of this study is to evaluate the safety and efficacy of abemaciclib plus tamoxifen or abemaciclib alone in women with previously treated hormone receptor-positive (HR+), human epidermal growth factor receptor 2 negative (HER2-), metastatic breast cancer.
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New targeted drug shows promise for lung cancer with MET mutations
Disease control OngoingThis study looked at how effective the study drug (tepotinib) was at stopping the growth and spread of lung cancer. This study also measures a number of other things including safety of the study drug and the side effects, how body processes the study drug, or how the study drug …
Phase 2 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New stent aims to fix aortic aneurysms without open surgery
Disease control OngoingThe objective of this study is to determine whether the GORE® TAG® Thoracic Branch Endoprosthesis is safe and effective in treating lesions of the aortic arch and descending thoracic aorta, requiring Zone 2 proximal implantation of the device.
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
A pill a day: testing a new shield against HIV for women
Prevention CompletedThe overall aim of this study is to assess attitudes toward PrEP, feasibility of Truvada PrEP procurement through the established access procedures, and adherence to Truvada PrEP among US women at risk for HIV acquisition.
Phase 4 • Sponsor: Rutgers, The State University of New Jersey • Aim: Prevention
Last updated Aug 15, 2026 00:00 UTC
-
Blood-Cleansing device shows promise for dangerous pregnancy condition
Disease control CompletedThis clinical investigation is a medical device trial to examine the safety and efficacy of TheraSorb sFlt-1 adsorber treatment of pregnant patients with preeclampsia.
Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Eye injection shows promise against fungal ulcers
Disease control CompletedMycotic Antimicrobial Localized Injection (MALIN) is a randomized, masked, two-arm clinical trial investigating intrastromal voriconazole in the treatment of fungal corneal ulcers. There is currently little evidence to guide the treatment of fungal keratitis beyond topical anti-f…
Phase 3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control OngoingThis phase II trial studies cediranib maleate in combination with olaparib in treating patients with solid tumors that have spread to other parts of the body (advanced/metastatic) or cannot be removed by surgery (unresectable), including breast cancer, non-small cell lung cancer,…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug shows promise for tough prostate cancer
Disease control CompletedThe purpose of this study is to assess the efficacy, safety, and pharmacokinetics of niraparib in men with metastatic castration-resistant prostate cancer (mCRPC) and deoxyribonucleic acid (DNA) repair anomalies.
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Heat and radiation team up to fight spine cancer
Disease control OngoingThis phase II clinical trial studies how well thermal ablation and spine stereotactic radiosurgery work in treating patients with cancer that has spread to the spine (spine metastases) and is at risk for compressing the spinal cord. Thermal ablation uses a laser to heat tumor tis…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
AI could help ovarian cancer patients get surgery at the right time
Knowledge-focused OngoingThis study integrates data from the randomized controlled SUNNY trial (RCT) and real-world (RWD) data, and employs multimodal data fitting to construct a medical artificial intelligence model to identify the clinical characteristics of patient subgroups suitable for primary debul…
Sponsor: Shanghai Gynecologic Oncology Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Targeted radiation boosts standard care for lung cancer that has spread a little
Disease control OngoingThe trial will assess the addition of stereotactic ablative radiotherapy (SABR) to standard anti-cancer therapy (SACT) in patients with oligometastatic non-small cell lung cancer. Patients will be randomised to receive either standard treatment alone (SACT) or standard treatment …
Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New vaccine trial aims to prevent breast cancer return
Vaccine OngoingThe purpose of this research study is to evaluate Immunotherapy with a peptide vaccine and Programmed Death Ligand 1 (PD-L1) inhibitor as a possible adjuvant treatment for Stage II or III Triple Negative Breast Cancer. This research study is studying the safety, tolerability, and…
Phase 1 • Sponsor: Massachusetts General Hospital • Aim: Vaccine
Last updated Jun 27, 2026 07:52 UTC
-
Breathing-Guided radiation aims to protect healthy lung tissue
Disease control CompletedThe purpose of this study is to develop radiation plans that will help preserve lung function in healthy tissue surrounding the tumor. We believe that 4DCT scans can be useful in designing radiation treatment plans that help us avoid healthy normal functioning lung tissue close t…
Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC